Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Burning sensation, Muscular weakness, Neuralgia, Pain in extremity
Clinical narrative: Hives; Sore Arm; Sore wrist; red rash on chest; nerve pain - right arm; tremors - right arm; weakness - right arm; burning sensation -right arm; itchiness; Rash near her ncek/rash on left side neck/collar bone; This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (Hives), PAIN IN EXTREMITY (Sore Arm), NEURALGIA (nerve pain - right arm), TREMOR (tremors - right arm) and MUSCULAR WEAKNESS (weakness - right arm) in a 37-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Nerve damage. Concurrent medical conditions included Allergy to chemicals (Contrast dye) and Allergy to vaccine (Allergy to Gardasil vaccine).    On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Feb-2021, the patient experienced RASH (Rash near her ncek/rash on left side neck/collar bone). On 27-Feb-2021, the patient experienced NEURALGIA (nerve pain - right arm), TREMOR (tremors - right arm), MUSCULAR WEAKNESS (weakness - right arm), BURNING SENSATION (burning sensation -right arm) and PRURITUS (itchiness). On 02-Mar-2021, the patient experienced RASH ERYTHEMATOUS (red rash on chest). On an unknown date, the patient experienced URTICARIA (Hives), PAIN IN EXTREMITY (Sore Arm) and ARTHRALGIA (Sore wrist). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) ongoing since an unknown date for Burning sensation, Rash, Hives and Pruritus, at a dose of 2 x 25 mg tablets; FEXOFENADINE HYDROCHLORIDE (ALLEGRA) ongoing since an unknown date for Rash, at an unspecified dose and frequency; ALPRAZOLAM (ATARAX [ALPRAZOLAM]) ongoing since an unknown date for Rash erythematous, at a dose of 25 mg; EPINEPHRINE (EPIPEN) ongoing since an unknown date for Hives, at an unspecified dose and frequency and LORAZEPAM (ATIVAN) ongoing since an unknown date at an unspecified dose and frequency. On 27-Feb-2021, RASH (Rash near her ncek/rash on left side neck/collar bone) had resolved. On 08-Mar-2021, NEURALGIA (nerve pain - right arm), TREMOR (tremors - right arm), MUSCULAR WEAKNESS (weakness - right arm), BURNING SENSATION (burning sensation -right arm) and PRURITUS (itchiness) had resolved. On 23-Mar-2021, RASH ERYTHEMATOUS (red rash on chest) had resolved. At the time of the report, URTICARIA (Hives), PAIN IN EXTREMITY (Sore Arm) and ARTHRALGIA (Sore wrist) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   The patient reported that following her visit to the neurologist on 12-Mar-2021, she completed antibody testing as ordered by her allergist and was found to have antibodies present. She reported that most of her symptoms had improved by the time she was ready for Dose 2 on 26March2021. However, MD at vaccination site told her she was not able to get the Dose 2 of Moderna vaccine or any mRNA vaccine due to the mild hives that she experienced at Dose 1 as per CDC guidelines. Moreover, patient also contacted CDC to ask f she can get Dose 2 of Moderna and Johnson & Johnson COVID-19 vaccine was recommended but that there was no data on the mixing of vaccinations and it would be at the discretion of the caller and primary care physician.  Concomitant medications were not reported   Most recent FOLLOW-UP information incorporated above includes: On 30-Apr-2021: Significant follow-up appended